Connor, Clark & Lunn Investment Management (CC&L)’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
|
|||||
|
2025
Q1 | $15.6M | Buy |
|
|||||
|
2024
Q4 | $17.9M | Buy |
|
|||||
|
2024
Q3 | $9.77M | Buy |
|
|||||
|
2024
Q2 | $9.5M | Buy |
|
|||||
|
2024
Q1 | $266K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $9.52M | Sell |
|
|||||
|
2023
Q2 | $11.2M | Sell |
|
|||||
|
2023
Q1 | $16.5M | Buy |
|
|||||
|
2022
Q4 | $15.1M | Sell |
|
|||||
|
2022
Q3 | $17.4M | Buy |
|
|||||
|
2022
Q2 | $1.34M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $386K | Sell |
|
|||||
|
2020
Q4 | $1.27M | Sell |
|
|||||
|
2020
Q3 | $1.19M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $250K | Buy |
|